Tuesday, April 28, 2015

Fed Strategy from Mohammed Ali

Bernanke's actions last week - failing to taper, yet still trying to maintain the illusion that QE is a good thing - are setting up a one-two punch that's not unlike boxing champion Mohammed Ali's famous "float like a butterfly, sting like a bee" approach.

If you recall, Ali was a master of the combination - some say the best ever. He loved to bring his opponents in close. Ali could see through the duplicity of his opponents' strategy and land punches that won decisively.

Ali did that using combinations that were based in fighting terms on two contrasts: high-low or short-long, or even left and right. He pressed every advantage he could find, even when others thought there were none to be had. Knowing he wanted to go the full 15 rounds, Ali developed a strategy that would become known as the "rope-a-dope" as a means of tiring out his opponents early on, then vanquishing them in later rounds when the fight really began.

I think we should take a page from Ali's playbook and split the "fight" Bernanke's presented us with into two distinct time zones: the current "round," and those that happen down the line. One short. One long.

Is that possible?

Absolutely. What's more, it's easy to do.

First, though, put yourself in Bernanke's place...

Losing His "Final Round" Would Crush You, the Markets, and Bernanke Himself

For all the lip service he pays to wanting growth, in reality, Bernanke's game is all about defense... from the moment he wakes up to the moment he goes to bed.

Why is pretty simple.

Right now, he has to keep a lid on everything from the looming budget battle to the Middle East. His risk is that the consumer gets crushed if he doesn't. So he's going to keep buying, lest he create a market crash that goes down on his watch, destroying his reputation and vaporizing the rumored $10 million advance for his memoir.

Longer term, he's got trillions of reasons why he doesn't want to pop the bubble, the most important of which is that he doesn't want to lose control over the bond markets and, by implication, interest rates.

The rub is that he will anyway. And I think Chairman Bernanke is acutely aware of that now, because derivatives traders are beginning to circle like sharks sensing blood in the water.

Factor in trillions of dollars, and there's enough fuel to drive rates higher for decades after he's gone, especially if you look at how far rates have fallen.

Since 1981, they've plummeted from 15% to a mere 3.46%, as of Monday.

20 year treasury constant maturity rate gs20

The far more likely course of action is that they rise like they did from 1950 to 1981... especially when you look at the bigger picture and understand that interest rates move in multi-decade cycles.

20 year treasury constant maturity rate gs20

(By the way, if you're wondering why there's no data from January 1, 1987, through September 30, 1993... The Fed discontinued the 20-year constant maturity series at the end of the calendar year 1986 and reinstated the series on October 1, 1993.)

A One-Two Investment Approach

1. For the near term, try the Pimco Strategic Global Government Fund (NYSE: RCS).

Managed by Allianz Global Investors Fund Management LLC, the fund is constructed of intermediate-term, high-quality government securities. The fund can invest in mortgage-related and asset-backed securities, too, if managers so desire. It's also got the flexibility to pick up foreign paper.

The dividends are paid monthly, which means that income-hungry investors will get cold, hard cash in their accounts regularly. That's not insignificant, considering the yield is a healthy 9.2% as of press time, according to Allianz.

2. For the longer term, I can't think of a better pick than the ProShares Short 20+ year Treasury (NYSE Arca: TBF).

This ETF is one of a specialized class of inverse funds that zigs when the universe around which it's constructed zags. In this case, TBF is designed to appreciate while longer-term U.S. bonds deteriorate.

As its name implies, the fund concentrates investments in U.S. Treasury securities with maturity dates longer than 20 years. That's great, because longer-dated maturities are the most volatile in the face of rising interest rates and, therefore, potentially offer some really great returns.

There's no yield, and the 0.95% in expenses doesn't make this the cheapest alternative out there, but I like the liquidity afforded us by the $1.47 billion in assets. It's also unleveraged, which means that performance-reducing tracking error that plagues similar double- and triple-leveraged funds is minimized.

At the end of the day, it's important to remember that interest rates will return to normal sooner or later, and these two investments will help you capture profits that can be yours for the taking when they do.

You don't have to play defense even if Bernanke does.

Best regards for great investing,

Keith

P.S. If you're wondering about equities, I'll be back in a few days with my take. But here's a hint if you just can't wait: Equities remain under-owned compared to bonds - this despite a 135% run up off March 2009 lows, and despite Bernanke's near laser-like focus on cheap money. So there's an incentive for the institutions to lever up even further and, in the process, goose stock market returns through the balance of the year. I know that with the S&P 500 and Dow waffling this week that this is hard to imagine, but don't forget - so was the concept of trillions of dollars of stimulus a few years ago.

Next: "The Secret to Superior Returns," where Keith shares one of the key strategies driving his Money Map Report's outstanding total return...

What to Look For This Earnings Season? - Ahead of Wall ...

Monday, July 8, 2013

Friday's strong jobs report shed a positive light on the labor market and likely increased the odds of Fed 'tapering' in the coming months. The bond market's move towards pricing in such an outcome has thankfully not become a problem for the stock market, at least not yet. We will know more later this week as minutes of the last FOMC meeting get released. But at this stage, the stock market is taking the 100 basis point jump in benchmark yields since early May in the stride.

Thankfully for us, the focus shifts from the Fed this week to the 2013 Q2 earnings season with the earnings reports from Alcoa (AA) later today and Yum Brands (YUM), J.P. Morgan (JPM) and Wells Fargo (WFC) later this week. Expectations remain low enough that companies wouldn't face much difficulty coming ahead of them. About two-thirds of companies beat earnings expectations in a typical quarter any way and there is no reason to think that the Q2 earnings season will be any different. My sense is that earnings growth and earnings surprises in the Q2 reporting cycle would be along the lines of what we saw in Q1.

Current expectations are for +0.4% growth in total earnings in Q2, down from +3.9% in early April, while total S&P 500 earnings increased by +2.8% in Q1. Nine of the 16 Zacks sectors are expected to show negative earnings growth in Q2. The growth picture in is even more underwhelming when Finance is excluded from the data. Outside of Finance, total earnings for the S&P 500 would be down -3.2% in Q2.

But even more significant than growth rates and surprises will be guidance. Guidance is always important, but it will likely be far more important this time around given the elevated expectations for the second half of the year. Total earnings are expected to be up +5.1% in 2013 Q3 and by +11.7% in Q4, giving us a second-half growth pace of +9.2% from the same period the year before, which comes after +2.7% earnings growth in the first half. Importantly, the gr! owth expectations for the second half are not due to easy comparisons – the level of total earnings expected in 2013 Q3 and Q4 represent new all-time high quarterly records.

My sense is that estimates need to come down in a big way. The market hasn't cared much in the recent past about negative revisions as aggregate earnings estimates have been coming down for over a year now. But if we are entering a post-QE world, as I believe we are, then it will likely be difficult to overlook negative earnings estimate revisions going forward. How the market responds to negative guidance over and the resulting negative revisions will tell us a lot about what to expect going forward.

Sheraz Mian
Director of Research

Monday, April 20, 2015

2 Health Care Stocks Rising on Big Volume

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track big changes in volume activity. Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Major moves in volume can signal unusual activity, such as insider buying or selling -- or buying or selling by "superinvestors."

Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst. These types of traders like to get in well before a large spike, so it's always a smart move to monitor unusual volume. That said, remember to combine trend and price action with unusual volume. Put them all together to help you decipher the next big trend for any stock.

With that in mind, let's take a look at several stocks rising on unusual volume today.

Alkermes

Alkermes (ALKS) is engaged in developing, manufacturing and commercializing medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious diseases. This stock closed up 2% to $33.63 in Monday's trading session.

Monday's Volume: 3.14 million

Three-Month Average Volume: 1.51 million

Volume % Change: 98%

From a technical perspective, ALKS trended up here and broke out above some near-term overhead resistance at $34.30 with heavy upside volume. This move also pushed shares of ALKS into new 52-week-high territory, since the stock hit an intraday high of $34.74.

Traders should now look for long-biased trades in ALKS as long as it's trending above $31.50 and then once it sustains a move or close above Monday's high of $34.74 with volume that hits near or above 1.51 million shares. If we get that move soon, then ALKS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $40 to $43.

Actavis

Actavis (ACT) is a global, integrated specialty pharmaceutical company engaged in developing, manufacturing and distributing generic, brand and biosimilar products. This stock closed up 1.3% at $134.48 in Monday's trading session.

Monday's Volume: 2.44 million

Three-Month Average Volume: 1.76 million

Volume % Change: 59%

Shares of ACT spiked modestly higher on Monday after Leerink upgraded the stock to outperform from market perform, citing valuation and confidence in the company's ability to beat earnings expectations. The firm raised its price target to $155 from $133.

From a technical perspective, ACT trended up here and broke out above its 52-week and three-year highs at $133 with above-average volume. This breakout is coming off a major base and consolidation pattern for shares of ACT, since the stock had previously been trending range-bound between $118.68 on the downside and $133 on the upside.

Traders should now look for long-biased trades in ACT as long as it's trending above $130 or $128 and then once it sustains a move or close above its new 52-week high at $135.99 with volume that's near or above 1.76 million shares. If we get that move soon, then ACT will set up to enter new 52-week- and three-year-high territory, which is bullish technical price action. Some possible upside targets off that move are $140 to $145, or even $150 to $155.

To see more stocks rising on unusual volume, check out the Stocks Rising On Unusual Volume portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.

Tuesday, April 14, 2015

Ahead of Apple's Entry, Google Is Pushing Payments

The mobile payments industry doesn't have clear leadership right now. There are a slew of companies trying to tap the space, including eBay's PayPal and start-ups like Square, but no contender has emerged as the dominant player.

Of the five tech giants currently at war, Apple (NASDAQ: AAPL  ) and Google (NASDAQ: GOOG  ) have the most immediate structural advantages since mobile payments will inevitably be driven by smartphones, and iOS and Android power over 90% of all smartphones sold. Amazon.com has 209 million active customer accounts with payment info on file, but the e-tailer doesn't operate a smartphone platform (yet).

Google is a first-mover in mobile payments with Google Wallet, but it has failed to move the needle even after launching two years ago. Meanwhile, Apple hasn't made any official forays, instead only offering Passbook that doesn't have a direct way to make payments. The Mac maker is widely expected to enter in a big way as early as this fall, since the iPhone 5S will likely include a fingerprint sensor for biometric security. Those 575 million active iTunes accounts are just waiting to be tapped.

Mobile payments are too important to ignore, and Google is making a renewed push with Wallet ahead of Apple's presumed entry. The search giant has launched a fresh promotion to encourage developers to integrate Google Wallet into their apps. At Google I/O in May, the company had also unveiled a new application programming interface, or API, for developers to integrate Google Wallet into their Android apps. Google said only 3% of shoppers on mobile devices complete checkouts because there are so many steps.

Big G is broadening its horizons beyond just in-app purchases of virtual goods; Google is facilitating the payments for third-party merchants selling physical goods and services.

Apple's key differentiator may be the expected integrated fingerprint sensor, which is something that Google can't uniformly support since that's a hardware element -- a decision that falls into OEM jurisdiction. For now, Google has a first-mover advantage over Apple, which it should aggressively exploit before the iPhone maker shakes things up.

The war among the five tech titans is heating up, and mobile payments will be an important battleground to strengthen platform loyalty. Payments are just one skirmish in the grand scheme of things, and there are a plethora of other dimensions where the big five will compete. Read more for free by clicking here.

Sunday, April 5, 2015

Why GRN Is Poised to Keep Plunging

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, the iPath Global Carbon ETN (NYSEMKT: GRN  ) has received the dreaded one-star ranking.

With that in mind, let's take a closer look at GRN and see what CAPS investors are saying about the ETF right now.

GRN facts

Inception

June 2008

Total Net Assets

$920 thousand

Investment Approach

Seeks to replicate the Barclays Capital Global Carbon Index Total Return. The index is designed to measure the performance of the most liquid carbon-related credit plans and is designed to be an industry benchmark for carbon investors.

Expense Ratio

0.75%

1-Year / 3-Year / 5-Year Return

(56.6%) / (42%) / (36.2%)

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 54% of the 28 members who have rated GRN believe the ETF will underperform the S&P 500 going forward.

Just yesterday, one of those Fools, All-Star TerryHogan, succinctly summed up the GRN bear case for our community:

People are too busy looking for jobs to care about carbon emissions. Besides, there is already a huge transition to cleaner forms of energy (Natgas is so cheap in North America). Until China and India are growing faster than [8% per year] I'm not too bullish on the future of carbon credits.

If you want market-thumping returns, you need to protect your portfolio from any undue risk. Luckily, our special report on ETFs highlights three funds that are poised to soar in the next recovery. It's 100% free, but won't last forever, so click here to access it now.